These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29050982)

  • 1. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
    Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
    Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
    Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-gastric cancer effect of Salidroside through elevating miR-99a expression.
    Yang L; Yu Y; Zhang Q; Li X; Zhang C; Mao T; Liu S; Tian Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3500-3510. PubMed ID: 31432697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway
    Li Y; Guo QJ; Chen R; Zhao L; Cui X; Deng Y; Luo YS
    Curr Cancer Drug Targets; 2024; 24(8):835-845. PubMed ID: 37718528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUSP6 Inhibitor (E/Z)-BCI Hydrochloride Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Murine Macrophage Cells via Activating the Nrf2 Signaling Axis and Inhibiting the NF-κB Pathway.
    Zhang F; Tang B; Zhang Z; Xu D; Ma G
    Inflammation; 2019 Apr; 42(2):672-681. PubMed ID: 30506106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
    Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
    Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
    Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y
    Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
    Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Liu SQ; Xu CY; Qin MB; Tan L; Zhuge CF; Mao YB; Lai MY; Huang JA
    Oncol Rep; 2015 Jun; 33(6):2871-82. PubMed ID: 25962735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways.
    Wei J; Wang R; Lu Y; He S; Ding Y
    Eur J Pharmacol; 2022 Feb; 916():174631. PubMed ID: 34774850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects and mechanism of α-mangostin on chemosensitivity of gastric cancer cells.
    Li RR; Zeng DY
    Kaohsiung J Med Sci; 2021 Aug; 37(8):709-717. PubMed ID: 34003591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.